Shenzhen YHLO Biotech Co (SHSE:688575) Change In Receivables : ¥0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co Change In Receivables?

Shenzhen YHLO Biotech Co's change in receivables for the quarter that ended in Sep. 2024 was ¥0 Mil. It means Shenzhen YHLO Biotech Co's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Shenzhen YHLO Biotech Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥13 Mil. It means Shenzhen YHLO Biotech Co's Accounts Receivable declined by ¥13 Mil from Dec. 2022 to Dec. 2023 .

Shenzhen YHLO Biotech Co's Accounts Receivable for the quarter that ended in Sep. 2024 was ¥403 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shenzhen YHLO Biotech Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 84.66.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shenzhen YHLO Biotech Co's liquidation value for the three months ended in Sep. 2024 was ¥-384 Mil.

Shenzhen YHLO Biotech Co Change In Receivables Historical Data

The historical data trend for Shenzhen YHLO Biotech Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen YHLO Biotech Co Change In Receivables Chart

Shenzhen YHLO Biotech Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-34.87

-58.25

-54.96

-190.33

12.93

Shenzhen YHLO Biotech Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shenzhen YHLO Biotech Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shenzhen YHLO Biotech Co (SHSE:688575) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shenzhen YHLO Biotech Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	402.516	/	433.826	*	91
=	84.66

2. In Ben Graham's calculation of liquidation value, Shenzhen YHLO Biotech Co's accounts receivable are only considered to be worth 75% of book value:

Shenzhen YHLO Biotech Co's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	469.382	-	1487.675	+	0.75 * 402.516	+	0.5 * 665.216
=	-384

Shenzhen YHLO Biotech Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen YHLO Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116

Website

http://www.szyhlo.com

Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.

Executives

Xiao Yu Jin	senior management
Liao Li Sheng	Directors, senior managers
Pang Shi Hong	senior management
Song Yong Bo	Directors, senior managers
Hu Kun Hui	Director
Xia Fu Zhen	Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines